ArticleP & T : a peer-reviewed journal for formulary management2010

Efficacy and safety of a lower-dose valganciclovir (valcyte) regimen for cytomegalovirus prophylaxis in kidney and pancreas transplant recipients.

Vrinda Bhat et al.PubMed ↗Full text ↗

No numbers read from the abstract.